1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Whole Exome Sequencing Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Whole Exome Sequencing Market, by Product & Service
8.1.1. Sequencing Platforms
8.1.1.1. Market Revenue and Forecast
8.1.2. Consumables (Kits, Reagents)
8.1.2.1. Market Revenue and Forecast
8.1.3. Services (Sequencing & Analysis)
8.1.3.1. Market Revenue and Forecast
9.1. Whole Exome Sequencing Market, by Technology
9.1.1. Short-Read Sequencing
9.1.1.1. Market Revenue and Forecast
9.1.2. Long-Read Sequencing
9.1.2.1. Market Revenue and Forecast
10.1. Whole Exome Sequencing Market, by Application
10.1.1. Rare Genetic Diseases
10.1.1.1. Market Revenue and Forecast
10.1.2. Cancer & Oncology
10.1.2.1. Market Revenue and Forecast
10.1.3. Mendelian Disorders Research
10.1.3.1. Market Revenue and Forecast
10.1.4. Other Applications
10.1.4.1. Market Revenue and Forecast
11.1. Whole Exome Sequencing Market, by End User
11.1.1. Academic & Research Institutes
11.1.1.1. Market Revenue and Forecast
11.1.2. Clinical Laboratories
11.1.2.1. Market Revenue and Forecast
11.1.3. Hospitals
11.1.3.1. Market Revenue and Forecast
11.1.4. Pharmaceutical & Biotechnology Companies
11.1.4.1. Market Revenue and Forecast
12.1. Whole Exome Sequencing Market, by Workflow
12.1.1. Sequencing
12.1.1.1. Market Revenue and Forecast
12.1.2. Data Analysis & Interpretation
12.1.2.1. Market Revenue and Forecast
12.1.3. Sample Preparation
12.1.3.1. Market Revenue and Forecast
13.1. North America
13.1.1. Market Revenue and Forecast, by Product & Service
13.1.2. Market Revenue and Forecast, by Technology
13.1.3. Market Revenue and Forecast, by Application
13.1.4. Market Revenue and Forecast, by End User
13.1.5. Market Revenue and Forecast, by Workflow
13.1.6. U.S.
13.1.6.1. Market Revenue and Forecast, by Product & Service
13.1.6.2. Market Revenue and Forecast, by Technology
13.1.6.3. Market Revenue and Forecast, by Application
13.1.6.4. Market Revenue and Forecast, by End User
13.1.6.5. Market Revenue and Forecast, by Workflow
13.1.7. Rest of North America
13.1.7.1. Market Revenue and Forecast, by Product & Service
13.1.7.2. Market Revenue and Forecast, by Technology
13.1.7.3. Market Revenue and Forecast, by Application
13.1.7.4. Market Revenue and Forecast, by End User
13.1.7.5. Market Revenue and Forecast, by Workflow
13.2. Europe
13.2.1. Market Revenue and Forecast, by Product & Service
13.2.2. Market Revenue and Forecast, by Technology
13.2.3. Market Revenue and Forecast, by Application
13.2.4. Market Revenue and Forecast, by End User
13.2.5. Market Revenue and Forecast, by Workflow
13.2.6. UK
13.2.6.1. Market Revenue and Forecast, by Product & Service
13.2.6.2. Market Revenue and Forecast, by Technology
13.2.6.3. Market Revenue and Forecast, by Application
13.2.7. Market Revenue and Forecast, by End User
13.2.8. Market Revenue and Forecast, by Workflow
13.2.9. Germany
13.2.9.1. Market Revenue and Forecast, by Product & Service
13.2.9.2. Market Revenue and Forecast, by Technology
13.2.9.3. Market Revenue and Forecast, by Application
13.2.10. Market Revenue and Forecast, by End User
13.2.11. Market Revenue and Forecast, by Workflow
13.2.12. France
13.2.12.1. Market Revenue and Forecast, by Product & Service
13.2.12.2. Market Revenue and Forecast, by Technology
13.2.12.3. Market Revenue and Forecast, by Application
13.2.12.4. Market Revenue and Forecast, by End User
13.2.13. Market Revenue and Forecast, by Workflow
13.2.14. Rest of Europe
13.2.14.1. Market Revenue and Forecast, by Product & Service
13.2.14.2. Market Revenue and Forecast, by Technology
13.2.14.3. Market Revenue and Forecast, by Application
13.2.14.4. Market Revenue and Forecast, by End User
13.2.15. Market Revenue and Forecast, by Workflow
13.3. APAC
13.3.1. Market Revenue and Forecast, by Product & Service
13.3.2. Market Revenue and Forecast, by Technology
13.3.3. Market Revenue and Forecast, by Application
13.3.4. Market Revenue and Forecast, by End User
13.3.5. Market Revenue and Forecast, by Workflow
13.3.6. India
13.3.6.1. Market Revenue and Forecast, by Product & Service
13.3.6.2. Market Revenue and Forecast, by Technology
13.3.6.3. Market Revenue and Forecast, by Application
13.3.6.4. Market Revenue and Forecast, by End User
13.3.7. Market Revenue and Forecast, by Workflow
13.3.8. China
13.3.8.1. Market Revenue and Forecast, by Product & Service
13.3.8.2. Market Revenue and Forecast, by Technology
13.3.8.3. Market Revenue and Forecast, by Application
13.3.8.4. Market Revenue and Forecast, by End User
13.3.9. Market Revenue and Forecast, by Workflow
13.3.10. Japan
13.3.10.1. Market Revenue and Forecast, by Product & Service
13.3.10.2. Market Revenue and Forecast, by Technology
13.3.10.3. Market Revenue and Forecast, by Application
13.3.10.4. Market Revenue and Forecast, by End User
13.3.10.5. Market Revenue and Forecast, by Workflow
13.3.11. Rest of APAC
13.3.11.1. Market Revenue and Forecast, by Product & Service
13.3.11.2. Market Revenue and Forecast, by Technology
13.3.11.3. Market Revenue and Forecast, by Application
13.3.11.4. Market Revenue and Forecast, by End User
13.3.11.5. Market Revenue and Forecast, by Workflow
13.4. MEA
13.4.1. Market Revenue and Forecast, by Product & Service
13.4.2. Market Revenue and Forecast, by Technology
13.4.3. Market Revenue and Forecast, by Application
13.4.4. Market Revenue and Forecast, by End User
13.4.5. Market Revenue and Forecast, by Workflow
13.4.6. GCC
13.4.6.1. Market Revenue and Forecast, by Product & Service
13.4.6.2. Market Revenue and Forecast, by Technology
13.4.6.3. Market Revenue and Forecast, by Application
13.4.6.4. Market Revenue and Forecast, by End User
13.4.7. Market Revenue and Forecast, by Workflow
13.4.8. North Africa
13.4.8.1. Market Revenue and Forecast, by Product & Service
13.4.8.2. Market Revenue and Forecast, by Technology
13.4.8.3. Market Revenue and Forecast, by Application
13.4.8.4. Market Revenue and Forecast, by End User
13.4.9. Market Revenue and Forecast, by Workflow
13.4.10. South Africa
13.4.10.1. Market Revenue and Forecast, by Product & Service
13.4.10.2. Market Revenue and Forecast, by Technology
13.4.10.3. Market Revenue and Forecast, by Application
13.4.10.4. Market Revenue and Forecast, by End User
13.4.10.5. Market Revenue and Forecast, by Workflow
13.4.11. Rest of MEA
13.4.11.1. Market Revenue and Forecast, by Product & Service
13.4.11.2. Market Revenue and Forecast, by Technology
13.4.11.3. Market Revenue and Forecast, by Application
13.4.11.4. Market Revenue and Forecast, by End User
13.4.11.5. Market Revenue and Forecast, by Workflow
13.5. Latin America
13.5.1. Market Revenue and Forecast, by Product & Service
13.5.2. Market Revenue and Forecast, by Technology
13.5.3. Market Revenue and Forecast, by Application
13.5.4. Market Revenue and Forecast, by End User
13.5.5. Market Revenue and Forecast, by Workflow
13.5.6. Brazil
13.5.6.1. Market Revenue and Forecast, by Product & Service
13.5.6.2. Market Revenue and Forecast, by Technology
13.5.6.3. Market Revenue and Forecast, by Application
13.5.6.4. Market Revenue and Forecast, by End User
13.5.7. Market Revenue and Forecast, by Workflow
13.5.8. Rest of LATAM
13.5.8.1. Market Revenue and Forecast, by Product & Service
13.5.8.2. Market Revenue and Forecast, by Technology
13.5.8.3. Market Revenue and Forecast, by Application
13.5.8.4. Market Revenue and Forecast, by End User
13.5.8.5. Market Revenue and Forecast, by Workflow
14.1. Illumina, Inc.
14.1.1. Company Overview
14.1.2. Product Offerings
14.1.3. Financial Performance
14.1.4. Recent Initiatives
14.2. Thermo Fisher Scientific Inc.
14.2.1. Company Overview
14.2.2. Product Offerings
14.2.3. Financial Performance
14.2.4. Recent Initiatives
14.3. Agilent Technologies, Inc.
14.3.1. Company Overview
14.3.2. Product Offerings
14.3.3. Financial Performance
14.3.4. Recent Initiatives
14.4. Roche (Roche Sequencing / KAPA Biosystems)
14.4.1. Company Overview
14.4.2. Product Offerings
14.4.3. Financial Performance
14.4.4. Recent Initiatives
14.5. BGI Genomics
14.5.1. Company Overview
14.5.2. Product Offerings
14.5.3. Financial Performance
14.5.4. Recent Initiatives
14.6. Eurofins Scientific
14.6.1. Company Overview
14.6.2. Product Offerings
14.6.3. Financial Performance
14.6.4. Recent Initiatives
14.7. Macrogen, Inc.
14.7.1. Company Overview
14.7.2. Product Offerings
14.7.3. Financial Performance
14.7.4. Recent Initiatives
14.8. Qiagen N.V.
14.8.1. Company Overview
14.8.2. Product Offerings
14.8.3. Financial Performance
14.8.4. Recent Initiatives
14.9. Berry Genomics
14.9.1. Company Overview
14.9.2. Product Offerings
14.9.3. Financial Performance
14.9.4. Recent Initiatives
14.10. CD Genomics
14.10.1. Company Overview
14.10.2. Product Offerings
14.10.3. Financial Performance
14.10.4. Recent Initiatives
15.1. Primary Research
15.2. Secondary Research
15.3. Assumptions
16.1. About Us
16.2. Glossary of Terms
For questions or customization requests, please reach out to us at sales@precedenceresearch.com
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
